Phase 1 clinical trial of DES 7114 in healthy volunteers
Latest Information Update: 21 Jun 2022
At a glance
- Drugs LY 3972406 (Primary)
- Indications Immunological disorders
- Focus Adverse reactions
Most Recent Events
- 21 Jun 2024 According to an MR (9360801),DES 7114 completed phase 1 trials, for now I have created one CTP for the same. Kindly create new CTPs as and when more info is available.
- 21 Jun 2022 New trial record